Literature DB >> 3469098

Myopathy in Marinesco-Sjogren syndrome.

D W Superneau, W Wertelecki, H Zellweger, F Bastian.   

Abstract

Progressive muscular weakness, hypotonia and atrophy are among the cardinal signs of the Marinesco-Sjogren syndrome but have not been extensively investigated. Our study focused on 6 related patients who are members of an inbred population. Muscle biopsies revealed myopathic alterations with variation of fiber size, rounding, degeneration and regeneration of fibers, internalization of nuclei and endomysial fat and fibrosis. Most patients had elevated serum creatine kinase levels. One patient revealed endstage neuromuscular disease and had normal serum creatine kinase levels. Of particular interest was the finding of conspicuous myopathy in 2 young children. Thus far, it has not been appreciated that myopathy represents an early sign of the Marinesco-Sjogren syndrome.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3469098     DOI: 10.1159/000116305

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  10 in total

1.  Myopathy is a prominent feature in Marinesco-Sjögren syndrome: A muscle computed tomography study.

Authors:  Ibrahim Mahjneh; Anna-Kaisa Anttonen; Mirja Somer; Anders Paetau; Anna-Elina Lehesjoki; Hannu Somer; Bjarne Udd
Journal:  J Neurol       Date:  2005-09-15       Impact factor: 4.849

2.  Myopathy in Marinesco-Sjögren syndrome: an ultrastructural study.

Authors:  Y Goto; A Komiyama; Y Tanabe; Y Katafuchi; E Ohtaki; I Nonaka
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 3.  BiP and its nucleotide exchange factors Grp170 and Sil1: mechanisms of action and biological functions.

Authors:  Julia Behnke; Matthias J Feige; Linda M Hendershot
Journal:  J Mol Biol       Date:  2015-02-16       Impact factor: 5.469

Review 4.  MR imaging features in Marinesco-Sjögren syndrome: severe cerebellar atrophy is not an obligatory finding.

Authors:  Anke Reinhold; Ianina Scheer; Rüdiger Lehmann; Luitgard M Neumann; Theodor Michael; Raymonda Varon; Arpad Von Moers
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

5.  Sil1, a nucleotide exchange factor for BiP, is not required for antibody assembly or secretion.

Authors:  Viraj P Ichhaporia; Tyler Sanford; Jenny Howes; Tony N Marion; Linda M Hendershot
Journal:  Mol Biol Cell       Date:  2014-12-03       Impact factor: 4.138

Review 6.  Rhabdomyolysis: a genetic perspective.

Authors:  Renata Siciliani Scalco; Alice R Gardiner; Robert Ds Pitceathly; Edmar Zanoteli; Jefferson Becker; Janice L Holton; Henry Houlden; Heinz Jungbluth; Ros Quinlivan
Journal:  Orphanet J Rare Dis       Date:  2015-05-02       Impact factor: 4.123

7.  A nationwide survey on Marinesco-Sjögren syndrome in Japan.

Authors:  Masahide Goto; Mari Okada; Hirofumi Komaki; Kenji Sugai; Masayuki Sasaki; Satoru Noguchi; Ikuya Nonaka; Ichizo Nishino; Yukiko K Hayashi
Journal:  Orphanet J Rare Dis       Date:  2014-04-23       Impact factor: 4.123

8.  Characterization of Zebrafish Models of Marinesco-Sjögren Syndrome.

Authors:  Genri Kawahara; Yukiko K Hayashi
Journal:  PLoS One       Date:  2016-10-28       Impact factor: 3.240

9.  SIL1, the endoplasmic-reticulum-localized BiP co-chaperone, plays a crucial role in maintaining skeletal muscle proteostasis and physiology.

Authors:  Viraj P Ichhaporia; Jieun Kim; Kanisha Kavdia; Peter Vogel; Linda Horner; Sharon Frase; Linda M Hendershot
Journal:  Dis Model Mech       Date:  2018-05-10       Impact factor: 5.758

Review 10.  Role of the HSP70 Co-Chaperone SIL1 in Health and Disease.

Authors:  Viraj P Ichhaporia; Linda M Hendershot
Journal:  Int J Mol Sci       Date:  2021-02-04       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.